Blood · 2003 · 41 citations · 17 references
Life SciencesImmunologyAdaptive ImmunityImmunoregulationInnate ImmunityCell-mediated ImmunityImmune ResponseInnate Immune ResponseInterferon ResponsesNatural Killer Cell BiologyNatural Killer Cell FunctionCd8 Positive T CellsCd8 T Cell ActivationInterferon Gamma ProductionInterferon Gamma ResponseInterferon-gamma ResponsesInterferon-mediated Innate ImmunityType I Interferon Pathways
The mechanisms responsible for immunoglobulin G (IgG) immunity against allogeneic platelets are poorly understood. We studied the role that murine recipient CD8+ T and natural killer (NK) cells play in immunity against allogeneic platelets. BALB/c mice were depleted of the cells by cell-specific antibodies, transfused weekly with platelets from C57BL/6 mice, and serum IgG antidonor antibodies were measured by flow cytometry. While allogeneic platelet transfusions into wild-type recipients stimulated IgG antidonor antibodies in all mice by the fifth transfusion, CD8-depleted mice had significantly (P<.001) enhanced antibody production. Isotype analysis revealed that CD8+ T cells suppressed T-helper 2 (Th2)-associated IgG1 but enhanced Th1-associated IgG2a. Compared with wild-type mice, platelet transfusions into CD8-depleted mice stimulated enhanced intracellular interferon (IFN)-gamma production by CD4- lymphocytes within 24 hours after the first transfusion. The early IFN-gamma response correlated with nitric oxide-dependent splenic cytotoxicity (P<.001). In asialo ganglioside monosialic acid 1 (GM1)-depleted mice transfused with allogeneic platelets, the IFN-gamma production, splenic cytotoxicity, and IgG antidonor antibody response were significantly suppressed. These results demonstrate that IgG antiplatelet immunity is dependent on an early NK cell-derived IFN-gamma response that is negatively regulated by CD8+ T cells and suggest that targeting innate NK cell responses may significantly reduce platelet alloimmunization.
17
Lysis of tumor cells by natural killer cells in mice is impeded by platelets.
Bernhard Nieswandt, Michael Häfner, Bernd Echtenacher et al. · PubMed · 1999 · 838 citations
Life Sciences, Immunology, Oncology +13
The Trial to Reduce Alloimmunization to Platelets Study Group · New England Journal of Medicine · 1997 · 804 citations · Full text
Medicine, Hematology, Immunology +17
Platelet-Mediated Modulation of Adaptive Immunity
Bennett D. Elzey, Jun Tian, Robert J. Jensen et al. · Immunity · 2003 · 392 citations · Full text